In Treatment of Allergic conditions Clamist Tablet is used to treat many different inflammatory and allergic conditions. It helps treat runny nose, sneezing, itching, and watery eyes. It works by lowering your immune system’s response to these conditions and prevents the release of substances in the body that cause inflammation. It helps relieve symptoms such as swelling, pain, itching, and other allergic-type reactions. If you are not sure why you are being given this medicine, ask your doctor. This medicine is given orally (by mouth). You should always take it as it has been prescribed for you. Do not stop taking it without your doctor’s advice. This can cause unpleasant withdrawal symptoms. Because this medicine weakens your immune system, you should avoid being near people who are ill or have infections.
Clamist Tablet may cause excessive drowsiness with alcohol.
Clamist Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Clamist Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Larger doses or more prolonged use of Clamist Tablet may cause sleepiness and other effects in the baby.
Clamist Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur. Caution is advised when driving or operating machinery.
Clamist Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Clamist Tablet may not be needed in these patients. Please consult your doctor.
Clamist Tablet should be used with caution in patients with liver disease. Dose adjustment of Clamist Tablet may be needed. Please consult your doctor.
If you miss a dose of Clamist Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Novartis India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Novartis India Ltd || ₹14.5/tablet (25% cheaper)